Hummingbird Bioscience reels in $19 mln Series B

Hummingbird Bioscience, a biotherapeutics company, has raised $19 million in Series B financing.

Hummingbird Bioscience, a biotherapeutics company, has raised $19 million in Series B financing. Mirae Asset Venture Investment and GNTech Venture Capital led the round.

Source: Press Release